December 31st, 2018

BioVersys is featured in a Forbes France special

BioVersys is featured in a Forbes France special presenting 10 Swiss SME's to watch.

A link to the...


December 13th, 2018

Are Novel Antibiotics worth investing in?


December 5th, 2018

Press Release - New CDO at BioVersys - Dr. Glenn Dale

BioVersys is pleased to announce the appointment of Dr. Glenn Dale as Chief Development Officer as...


November 27, 2018

Fresh funds to fuel the fight against drug-resistant bacteria

BioVersys together with BioSystems Technology and Voxcan announced funding - € 840,000 over a...

http://c1940652.r52.cf0.rackcdn.com/58528159b8d39a3eff000d0c/news1.jpg